Cargando…

Integration of real-world evidence from different data sources in health technology assessment

Real-world evidence (RWE) is being increasingly used by a wide range of stakeholders involved in the therapeutic product lifecycle but remains underutilized in the health technology assessment (HTA) process. RWE aims to fill the current evidence gaps, reduce the uncertainty around the benefits of me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graili, Pooyeh, Guertin, Jason R., Chan, Kelvin K. W., Tadrous, Mina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Science Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387532/ https://www.ncbi.nlm.nih.gov/pubmed/37529633 http://dx.doi.org/10.3389/jpps.2023.11460

Ejemplares similares

Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective
por: Wills, Allison, et al.
Publicado: (2023)

Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System
por: Yu, Zicheng, et al.
Publicado: (2023)

Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence
por: Helanterä, Ilkka, et al.
Publicado: (2022)

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020)

Adapting artificial intelligence into the evolution of pharmaceutical sciences and publishing: Technological darwinism
por: Davies, Neal M.
Publicado: (2023)

Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle
por: Tadrous, Mina, et al.
Publicado: (2020)

Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned
por: Evans, William K., et al.
Publicado: (2022)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
por: Lovas, Szilvia, et al.
Publicado: (2022)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
por: Szita, Virág Réka, et al.
Publicado: (2022)

Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
por: Dai, Wei Fang, et al.
Publicado: (2022)

Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
por: Raval, Amit D., et al.
Publicado: (2022)

Expression of Concern: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
Publicado: (2023)

The Real-World Impact of Vaccination on COVID-19 Cases During Europe’s Fourth Wave
por: Jain, Vageesh, et al.
Publicado: (2022)

Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome
por: Gupta, Tina, et al.
Publicado: (2021)

Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data
por: Revesz, Janos, et al.
Publicado: (2023)

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
por: Parmar, Ambica, et al.
Publicado: (2023)

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Real World Experience of a Single Center
por: Kopińska, A., et al.
Publicado: (2021)

Transferability of real-world data across borders for regulatory and health technology assessment decision-making
por: Jaksa, Ashley, et al.
Publicado: (2022)

Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis
por: Hirata, Ikkou, et al.
Publicado: (2023)

Remdesivir-induced conduction abnormalities: A molecular model-based explanation
por: Kingsley, Ryan, et al.
Publicado: (2023)

Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis
por: Matsui, Katsuhiko, et al.
Publicado: (2023)

The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study
por: Forgerini, Marcela, et al.
Publicado: (2023)

Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition
por: Abdallah, Yasmeen El Hajj, et al.
Publicado: (2023)

The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking
por: Wu, Mali, et al.
Publicado: (2023)

Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database
por: Tanaka, Junko, et al.
Publicado: (2023)

Grading pharmacists’ risk of complaints to a regulator: A retrospective cohort study
por: Morris, Katherine, et al.
Publicado: (2023)

Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome
por: Zhai, Leilei, et al.
Publicado: (2023)

A new method for investigating bioequivalence of inhaled formulations: A pilot study on salbutamol
por: Rezaei, Homa, et al.
Publicado: (2023)

Clinical observation of dexmedetomidine nasal spray in the treatment of sleep disorders on the first night after undergoing maxillofacial surgery: a single-center double-blind randomized controlled study
por: Wang, Ye, et al.
Publicado: (2023)

COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database
por: Nakao, Hiroka, et al.
Publicado: (2023)

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
por: Mohammed, Omima S., et al.
Publicado: (2023)

Traditional Chinese medicine for treating aplastic anemia
por: Guan, Jing, et al.
Publicado: (2023)

Swiss Implementation Science Network (IMPACT): A Crucial Building Block to Strengthen the Swiss Research Pipeline for Real-World Translation
por: Dhaini, Suzanne R., et al.
Publicado: (2021)

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC
por: Behnke, Anke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ug0i2mlnrd3bqta8iunc1lc9j